Kenneth Parks will join the company on June 6 and will oversee all of Mylan’s global finance functions, including accounting and control, financial planning and analysis, investor relations, treasury and tax.
The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.
The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs.
So far in 2016, there have been multiple Part D plans and PBMs that have been utilizing MAC drug pricing values that are "far below what would be considered to be reasonably approaching market prices for drugs," the letter noted.